Display options
Cite
Xu L, Lee BS, Asif S, et al. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014;6:547-54doi: 10.2147/IJWH.S57470.
Xu, L., Lee, B. S., Asif, S., Kraemer, P., & Inki, P. (2014). Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. International journal of women's health, 6547-54. https://doi.org/10.2147/IJWH.S57470
Xu, Ling, et al. "Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy." International journal of women's health vol. 6 (2014): 547-54. doi: https://doi.org/10.2147/IJWH.S57470
Xu L, Lee BS, Asif S, Kraemer P, Inki P. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014 May 27;6:547-54. doi: 10.2147/IJWH.S57470. eCollection 2014. PMID: 24920936; PMCID: PMC4043813.
Copy Download .nbib Format: NLM
Share it on

Int J Womens Health. 2014 May 27;6:547-54. doi: 10.2147/IJWH.S57470. eCollection 2014.

Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy.

International journal of women's health

Ling Xu, Byung Seok Lee, Shaheena Asif, Peter Kraemer, Pirjo Inki

Affiliations

  1. Department of Gynecology and Obstetrics, Peking Union Medical College Hospital, Beijing, People's Republic of China.
  2. Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea.
  3. Department of Gynaecology and Obstetrics, Surgimed Hospital, Lahore, Pakistan.
  4. Global Medical Affairs Excellence and Operations, Berlin, Germany.
  5. Global Medical Affairs Women's Healthcare, Bayer HealthCare, Berlin, Germany.

PMID: 24920936 PMCID: PMC4043813 DOI: 10.2147/IJWH.S57470

Abstract

PURPOSE: To evaluate the patient satisfaction and health related quality of life (HRQoL) for levonorgestrel-releasing intrauterine system (LNG-IUS) versus conventional medical treatments ([CMTs] combined oral contraceptives, oral progestins, and antifibrinolytics, alone or in combination) in Asian women with heavy menstrual bleeding (HMB).

PATIENTS AND METHODS: A total of 647 patients diagnosed with HMB were recruited to this non-interventional study from the eight participating countries in Asia. Patient satisfaction was recorded at the last visit (at 12 months or premature discontinuation). At each visit (at 3, 6, and 12 months), patients completed the menorrhagia multi-attribute scale (MMAS) to assess HRQoL.

RESULTS: A total of 83.5% of patients on the LNG-IUS were "very satisfied" or at least "satisfied" with the therapeutic effect of HMB treatment, compared with 59.2% of patients with CMTs (P<0.05). The mean (± standard deviation) MMAS score increased from 41.4±24.5 to 87.7±21.4 in the LNG-IUS arm, and from 44.1±24.9 to 73.1±25.3 in the CMTs arm. This increase was significantly higher in patients on the LNG-IUS, as compared with those on CMTs (P<0.05). The improvement in HRQoL in both treatment groups correlated with the body mass index of the patient, with larger improvement obtained in women with a higher body mass index.

CONCLUSION: The majority of women using the LNG-IUS or CMTs for HMB were satisfied with their treatment, and both treatment modalities were associated with significant improvements in HRQoL over time. The improvement was greater with the LNG-IUS, compared with CMTs.

Keywords: HRQoL; MMAS; dysfunctional uterine bleeding; menorrhagia; tranexamic acid

References

  1. Qual Health Care. 1996 Mar;5(1):9-12 - PubMed
  2. Contraception. 2011 Jan;83(1):48-54 - PubMed
  3. Int J Womens Health. 2012;4:413-21 - PubMed
  4. Obstet Gynecol. 2010 Dec;116(6):1455-1456 - PubMed
  5. Fertil Steril. 2001 Jul;76(1):125-31 - PubMed
  6. Drugs. 2012 Jan 22;72(2):193-215 - PubMed
  7. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001016 - PubMed
  8. Int J Gynaecol Obstet. 2011 Mar;112(3):171-8 - PubMed
  9. JAMA. 2004 Mar 24;291(12):1456-63 - PubMed
  10. Contraception. 2013 Jan;87(1):107-12 - PubMed
  11. Womens Health (Lond). 2011 Sep;7(5):513-24 - PubMed
  12. J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):75-80 - PubMed
  13. Eur J Obstet Gynecol Reprod Biol. 2002 Sep 10;104(2):96-104 - PubMed
  14. Br J Obstet Gynaecol. 1998 Nov;105(11):1155-9 - PubMed
  15. Drug Saf. 2004;27(2):75-90 - PubMed
  16. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000154 - PubMed
  17. Int J Gynaecol Obstet. 2013 Apr;121(1):24-30 - PubMed
  18. N Engl J Med. 2013 Jan 10;368(2):128-37 - PubMed
  19. Drug Saf. 2008;31(4):275-82 - PubMed

Publication Types